From Breakthroughs Blog: CDC

 
Flickr/55thstreet
Global health and medical research saved from the chopping block in 2018 spending bill

What global health R&D advocates need to know about the 2018 omnibus spending bill.

Read More
Dr. Stephen Redd gives a tour of CDC’s Emergency Operations Center, which serves as a command center for monitoring and coordinating CDC’s emergency response activities to health threats in the United States and abroad. Photo credit: Mark Fletcher/CDC.
7 ways CDC is keeping us safe from deadly diseases

The threat is real: defunding the US Centers for Disease Control and Prevention  (CDC) puts us all in danger, in every country of the globe.

PATH
Read More
PATH/Evelyn Hockstein
Research Roundup: Plants as vaccines, the African CDC, and herd immunity in Zika

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Photo: White house/Shealah Craighead
Medical research, global health programs face steep cuts in Trump budget

On Tuesday, the Trump Administration released its full fiscal year 2018 budget proposal. This budget proposes significant cuts to programs that support global health and medical research at the National Institutes of Health, Centers for Disease Control and Prevention, and the US Agency for International Development.

Read More
PATH/Eric Becker
Research Roundup: The rise of drug-resistant TB, ecosystems and pandemics, and a UN-made global mosquito tracker

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Office of Management and Budget
Trump budget proposes steep cuts to research and foreign assistance that will threaten global health research

What global health advocates need to know about the President's "skinny" budget.

Read More
Flickr/Mark Taylor
Price addresses innovation, infectious diseases, NIH support at nomination hearings

At his nomination hearings, Secretary of Health and Human Services-designee Tom Price addressed global health and infectious diseases; innovation for rare diseases; support for health innovation, NIH, and priority setting for NIH-funded research. GHTC covers what he had to say.

Read More
GHTC/Marissa Chmiola
GHTC briefing highlights critical role of US government in advancing global health innovation in an increasingly globalized world

On Tuesday, GHTC launched our seventh annual policy report through a congressional briefing and panel discussion. The critical role played by the US government in catalyzing global health research and development was a recurring theme, as panelists discussed the interconnectedness of global and American health and emphasized the need for new health tools to protect against outbreaks and continue progress.

Read More
Why we need research to detect, prevent, and ultimately, eliminate parasitic diseases

In this guest post, Dr. Monica Parise—deputy director for program and science—and Dr. Larry Slutsker—director of the Division of Parasitic Disease and Malaria—at the US Centers for Disease Control and Prevention (CDC) Center for Global Health—discuss the role of research in advancing efforts to detect, prevent, and eliminate parasitic diseases.

Read More
The latest in MERS R&D: Do we have the tools needed to prevent the next outbreak?

Since its discovery in 2012, cases of Middle East Respiratory Syndrome (MERS)—a disease World Health Organization (WHO) Director-General Dr. Margaret Chan called “a threat to the entire world”— have been reported in 27 countries across four continents.

Read More
PATH/Patrick McKern
Research Roundup: publication of clinical trial results, the establishment of an African CDC, and more

The World Health Organization (WHO) released a statement last week calling for the publication of all data from clinical trials for drugs, vaccines, and medical devices.

Read More
US Centers for Disease Control and Prevention
Fighting for the future: Why we must come together to fight antibiotic resistance around the globe

I am pleased to have the opportunity to write about what is perhaps today’s most vexing public health challenge—the growing threat of antibiotic resistance.

Read More
PATH/Gabe Bienczycki
Research Roundup: discoveries in malaria research, remaining barriers to the development of an Ebola vaccine, and a diagnostic for maternal survival

Scientists at Karolinska Institutet in Sweden have identified the protein that explains why people with blood type O are protected from coma and death resulting from severe cases of malaria.

Read More
PATH/Evelyn Hockstein
Research Roundup: New TB drugs, the Global Development Lab, licensing agreements, emergency Ebola research, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New TB drug bedaquiline: Weighing the benefits against the risks

Earlier this month, advocates from the Community Research Advisors Group (CRAG)—an international, community-based advisory body working to ensure the engagement of affected communities in tuberculosis (TB) research conducted by the Centers for Disease Control and Prevention (CDC) —published an article in The Lancet offering a community perspective on the use of the drug bedaquiline to treat drug-resistant and drug-susceptible TB.

Read More
PATH/Evelyn Hockstein
Research Roundup: Saving Lives at Birth, US-Africa Leaders Summit, possible Ebola vaccine, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Amy MacIver
Research Roundup: Drug-resistant malaria, MDGs, World Breastfeeding Week, LHHS appropriations, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Anti-malaria drug resistance: a threat to global health security

In this guest post, S. Patrick Kachur, MD, MPH, FACPM—chief of the Malaria Branch in the Division of Parasitic Diseases and Malaria at the Center for Disease Control and Prevention’s (CDC) Center for Global Health—and Larry Slutsker, MD, MPH—director of the Division of Parasitic Diseases and Malaria at CDC’s Center for Global Health—write about the emerging global security threat of anti-malaria drug resistance and CDC’s efforts to prevent, detect, and respond to this growing threat.

Read More
Senate supports global health R&D in LHHS appropriations bill

Last week, we reported on exciting policy language included in the Senate Department of Defense appropriations legislation, and earlier this summer, the House and Senate State and Foreign Operations bills also included recognition of the role that new technologies could play in advancing global health.

GHTC
Read More
How R&D is saving #momandbaby and helping children reach their #5thbday

Tomorrow US policymakers and global health advocates will come together to talk progress made on preventing maternal and child deaths.

Read More
PATH/Will Boase
Congress acts on FY 2015 funding; shows lukewarm support for global health R&D

As the DC summer kicks into full swing, Congress has had a busy month moving forward fiscal year (FY) 2015 funding legislation for a variety of government programs including global health research and development (R&D).

GHTC
Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Satvir Malhotra
Global Health Security—A Priority for All

The US government’s recent commitment to global health security recognizes that health security is an essential part of every nation’s national security. As both Department of Health and Human Services Secretary Kathleen Sebelius and CDC Director Tom Frieden have said, “A health threat anywhere is a health threat everywhere.”

Read More
Ken Kistler
Congressional budget justifications shed light on FY 2015 global health R&D priorities

As more detailed information about the President’s fiscal year (FY) 2015 budget requests to Congress is released, the results continue to be a mixed bag for global health research and development (R&D).

GHTC
Read More
Obama Administration’s FY 2015 budget request sends mixed signals on global health R&D

Yesterday, the White House released President Obama’s much-anticipated budget request for fiscal year (FY) 2015.

GHTC
Read More
Ken Kistler
Congress passes FY 2014 Omnibus package: Mixed results for global health research

In an increasingly rare show of bipartisanship, Congress has moved forward an appropriations agreement that should finally settle the issue of fiscal year (FY) 2014 funding levels.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Three key research developments you might have missed from the ASTMH Annual Meeting

In this guest post, Jaclyn Schiff—American Society of Tropical Medicine and Hygiene (ASTMH) Director of Communications—highlights news in global health research presented during the recent ASTMH Annual Meeting.

Read More
Impacts of federal budget compromise emerging

After two-and-a-half weeks in limbo, government employees were able to return to work on October 17th—when Congress finally reached a temporary agreement to re-open the government.

GHTC
Read More
New fact sheet outlines the global health R&D pipeline and why US support is so important

In the past, the United States has contributed to important breakthroughs in global health—from the eradication of smallpox to a 74 percent drop in measles deaths worldwide.

GHTC
Read More
Budget compromise re-opens the federal government

In this guest post, Jenny Howell—senior policy & advocacy associate at PATH working with the GHTC—writes about the new budget compromise that re-opened the federal government, as well as the effect of the government shutdown on health research programs.

GHTC
Read More
Architect of the Capitol
Federal budget update, Part 2: DoD, CDC, FDA, and NIH

As we discussed yesterday, lawmakers in the House and Senate have been busy with several pieces of legislation that would fund global health and research efforts across the federal government.

GHTC
Read More
Senate committee approves spending bill for NIH, CDC

Today, the Senate appropriations committee approved a fiscal year (FY) 2014 appropriations bill that outlines funding levels for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

GHTC
Read More
Working to protect against the dangers of dengue

In this guest post, Dr. Claire Huang, a researcher with the Centers for Disease Control and Prevention’s (CDC) Division of Vector-Borne Diseases, describes a dengue vaccine candidate developed by her team.

Read More
Rapid, low-cost rabies test offers hope in Haiti

In this guest post, Jessie L. Dyer, MSPH, in the Centers for Disease Control and Prevention’s (CDC) Rabies Program, writes about the agency’s work with partners in Haiti to fight the disease.

Read More
The plague dipstick—Bringing the laboratory to the bedside

In this guest post, Dr. Martin Schriefer, chief of the Diagnostic and Reference Activity in the Bacterial Diseases Branch of the Division of Vector-Borne Diseases (DVBD) in Fort Collins, Colo., writes about his laboratory’s development of a new diagnostic tool, the plague dipstick.

Read More
21st century tools needed to confront 21st century global health challenges

In this guest post, Dr. Beth P. Bell, director of the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) at the Centers for Disease Control and Prevention (CDC), describes some of her center’s active engagement in global health work.

Read More
President’s FY2014 budget has varying news for global health and research programs

Wednesday, the White House released President Obama’s fiscal year (FY) 2014 budget request, which overall has mixed results for global health and research programs.

GHTC
Read More
New details emerging about sequestration that indicate an uncertain future for global health R&D

Although we’re several days into sequestration, details about the full impact of funding cuts are still hazy. On Friday, the Office of Management and Budget (OMB) released a report to Congress, which details funding cuts required to offset $85 billion in the fiscal year (FY) 2013 budget.

GHTC
Read More